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EDITORIAL
The role of transbronchial biopsy in the diagnosis of diffuse
parenchymal lung diseases: Con
O papel da biopsia transbrônquica no diagnóstico das doenc¸as difusas doI
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In order to engage in a focused pro/con debate, it is use-
ful to summarize key points of agreement, before reviewing
areas that remain contentious. It would be folly to deny
that in certain scenarios in diffuse parenchymal lung disease
(DPLD), the transbronchial biopsy (TBLB) has an invaluable
diagnostic role. In DPLD, histological support for a spe-
ciﬁc diagnosis can be obtained using TBLB in 29--79% of
cases.1 This wide range reﬂects the multiplicity of fac-
tors inﬂuencing the yield of the procedure, including the
distribution of the lesion (focal or diffuse), status of the
immune system of the patient, small size of the obtained
samples, confounding due to crush artifacts and failure to
penetrate beyond the peribronchial sheath.2,3 Despite these
limitations, we can all agree, based on diagnostic yields
of 65--90% in selected conditions,1 that TBLB is an appro-
priate ﬁrst biopsy procedure in many patients in whom
bronchocentric DPLDs are suspected, especially sarcoido-
sis and lympangitis carcinomatosis. In other disorders, TBLB
appearances are not diagnostically deﬁnitive in isolation but
allow the formulation of a conﬁdent diagnosis when inte-
grated with clinical data (including bronchoalveolar lavage)
and radiologic ﬁndings: this applies especially to cryptogenic
organizing pneumonia4 and, less often, to hypersensitiv-
ity pneumonitis. However, when it comes to the diagnosis
of individual idiopathic interstitial pneumonias (IIPs), a
very different consensus emerges. In the recently published
guidelines for the diagnosis of idiopathic pulmonary ﬁbrosis
(IPF)5 it was unanimously concluded that TBLB should not be
used to provide histologic support for a diagnosis of IPF. We
explore the rationale behind this recommendation, which
is diametrically opposed to the ‘‘pro’’ view in these paired
editorials.
The practical value of making a conﬁdent diagnosis is to
provide accurate information on the likely natural history
and/or treated course of disease in an individual patient.
Essentially, it can be argued that in DPLD, ‘‘diagnosis is prog-
nosis’’. No diagnostic test has consistent value in suspected
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doi:10.1016/j.rppneu.2011.09.004IP unless it helps materially in the identiﬁcation of IPF, the
ost prevalent IIP. A diagnosis of IPF has vital prognostic sig-
iﬁcance as the other IIPs have, on average, a much better
reated outcome.5 At present, it is accepted that the diag-
osis of IPF can be based on typical HRCT appearances and
compatible clinical picture in at least 50% of IPF cases.1
n the remaining cases, histolgical conﬁrmation of a pat-
ern of usual interstitial pneumonia (UIP) is required, with
he ﬁnal diagnosis made by consensus between histopatholo-
ists, radiologists and clinicians.5 The histological pattern of
IP is characterized by subpleural predominance of disease,
emporal heterogeneity (i.e. areas of established ﬁbrosis
uxtaposed with areas of active ﬁbrosis and normal lung) and
he presence of ﬁbroblastic foci.5 But which type of biopsy
rovides sufﬁciently accurate information for the formula-
ion of a diagnosis of IPF?
Until recently, it was viewed as axiomatic that a sur-
ical lung biopsy (SLB) was the ‘gold standard’ diagnostic
rocedure in DPLD. With the development of a multidis-
iplinary approach to diagnosis, it is now acknowledged
hat histologic information must be reconciled with clini-
al and radiologic data, but the central role of a diagnostic
LB in selected patients has not been seriously questioned.
one the less, the limitations of SLB should be acknowl-
dged. SLB cannot be performed in many patients because
ften advanced age, severity of the disease and pres-
nce of co-morbidities are major constraints. Moreover, the
nterpretation of SLB is subject to signiﬁcant interobserver
ariation. In a study undertaken by pathologists with spe-
ialist expertise in the ﬁeld of DPLD, the level of agreement
n the ﬁrst choice diagnosis was at the lower limit of what
ould be accepted as clinically useful, as judged by the
appa coefﬁcient of agreement.6 Lastly, there is the prob-
em of ‘‘sampling error’’, consisting of the identiﬁcation of
histologic pattern that is not representative of the pre-
ominant process.7,8 In IPF, areas of ﬁbrotic non speciﬁc
nterstitial pneumonia (NSIP) often exist and if captured at
gia. Published by Elsevier España, S.L. All rights reserved.
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LB, an incorrect ﬁnal diagnosis of NSIP may be made with
dverse effects on the accuracy of prognostication, selec-
ion of appropriate therapy and planning of transplantation.
Plainly, an alternative mode of biopsy that overcomes
hese problems with substantial loss of diagnostic accuracy
ould be invaluable and it is this unmet need that justiﬁes
eappraisal of the role of TBLB. But is TBLB intrinsically reli-
ble in the diagnosis of IPF and other IIPs, and does it address
he limitations of SLB listed above? It is our contention that
he answer to both questions is resoundingly negative.
In reality, it is difﬁcult to make deﬁnitive statements
n the accuracy of TBLB in the IIPs because of the lack
f a properly conducted diagnostic study, reﬂecting the
idespread view that IPF cannot be diagnosed with conﬁ-
ence using small TBLB samples. This perception is pivotal
ecause a tentative diagnosis, however accurate, is of lit-
le value in the formulation of a logical plan. As long as
his view remains prevalent, TBLB simply cannot provide the
ame diagnostic weight as SLB. However, it is worth con-
idering the study of Berbescu et al., if only to make the
oint that this most insubstantial of ‘‘diagnostic studies’’
annot be used to argue for a diagnostic role for TBLB in
PF.9 The authors retrospectively evaluated TBLB from 21
atients with surgical biopsy proven UIP and from 1 patient
ith clinical and radiological ﬁndings of IPF/UIP. They con-
luded that 7 of 22 patients had features ‘‘diagnostic’’ of
IP such as patchy interstitial ﬁbrosis along with ﬁbrob-
astic foci and/or honeycomb change, a rather miserable
ield of approximately 30%. From this small study, they
each the inexplicable conclusion that TBLB may be use-
ul in conﬁrming the diagnosis of UIP. The ﬂaw in the logic
s that the only patients included in this study had a ﬁnal
istologic diagnosis of UIP without ancillary SLB features sug-
estive of HP or alternative disorders such as connective
issue diseases. The authors are aware of patients ulti-
ately proven histologically to have sarcoidosis, in which
BLB ﬁndings of honeycombing and temporal heterogene-
ty were ‘‘strongly suggestive of UIP’’ (as described above).
uch patients could not, by deﬁnition, have been included
n the study of Berbescu. A UIP pattern is not infrequent
n hypersensitivity pneumonitis (HP) but the presence of
reas of bronchocentric inﬂammation and/or poorly formed
ranulomata (which are often sparse in large SLB samples)
re key diagnostic features which would, once again, have
xcluded these cases from the study discussed above. A TBLB
attern ‘‘compatible with UIP’’ will be actively misleading
f additional features indicative of HP, sarcoidosis or other
PLDs are missed in small TBLB samples. In essence, the
tatement that TBLB appearances were indicative of UIP in
ases proven by SLB to have UIP has negligeable diagnos-
ic value. The pivotal problem of false positive diagnosis is
ot acknowledged in the study of Berbescu, which cannot
e considered as a true diagnostic study. Indeed, the partic-
pating histopathologists were not blinded to the diagnosis
f UIP prior to reviewing the TBLB samples!
Thus, no data exist to suggest that TBLB might provide
seful support for a diagnosis of IPF but does this diagnostic
odality address the limitations of SLB? On the face of it,
BLB is a safer procedure as it does not require general anes-
hesia, has an overall mortality of 0.1% which is lower than
hat of SLB (approximately 1%) and can be performed as an
utpatient procedure.10--12 TBLB can be performed in some
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atients not ﬁt for SLB due to disease severity and presence
f co-morbidities. However, even this apparent advantage
an be questioned as inaccurate diagnoses carry their own
angers. Moreover, the other limitations of SLB -- diagnos-
ic interobserver variation and sampling error -- are present
o a much greater extent with the interpretation of TBLB
amples.
In the current literature, there are no studies of observer
ariation in the histologic interpretation of TBLB samples.
owever, the level of agreement between expert pul-
onary pathologists is only moderate with regard to the
nterpretation of SLB samples6,13 and must necessarily be
ore problematic for TBLB. The small size of the TBLB
nd the need to integrate TBLB appearances from several
iopsies into an overall histologic pattern carries its own
ariability, which must be added to the overall variabil-
ty of histologic interpretation. The problem of discordance
etween observers is compounded by the fact that small
BLB samples do not allow an assessment of the extent and
istribution of ﬁbrosis within the biopsied lobe. These lim-
tations can only be more problematic for less experienced
istopathologists, seeking to make a conﬁdent diagnosis of
IP using TBLB samples, applying the criteria proposed by
erbescu et al.9
Similarly, the problem of ‘‘sampling error’’ can only be
ncreased with the diagnostic use of TBLB. In IPF, it is now
ell recognized that in many patients, there are areas
f NSIP-like change. The ﬁnding of NSIP in one lobe and
IP in another lobe is not infrequent. Attempts to synthe-
ize a histologic diagnosis from TBLB, taken from only one
obe, cannot properly address this problem. Furthermore,
histologic pattern of UIP may also be present in chronic
ypersensitivity pneumonitis or rheumatoid lung. Ancillary
eatures suggestive of these disorders are often very lim-
ted in extent and are unlikely to be detected in a TBLB
pecimen. For example, the diagnosis of hypersensitivity
neumonitis will be strongly suspected when a UIP pattern
s bronchocentric in distribution and there are occasional
oorly formed granulomas, which will often be detected
nly with the examination of multiple biopsy ﬁelds. Simi-
arly, in rheumatoid lung, the suggestive observation that
ymphoid follicles are unusually prominent requires exami-
ation of suitably extensive biopsy tissue. Whether or not
hese key features are captured by TBLB can only be a
atter of chance. The conclusion is inescapable: whatever
‘sampling error’’ exists with the performance of a single
LB specimen can only be ampliﬁed by the diagnostic use of
BLB.
In an attempt to overcome these limitations, it has been
roposed that the use of larger forceps via rigid bron-
hoscope would increase the diagnostic yield of TBLB14
nd avoid crush artifacts. In a keynote series, the authors
bserved that in 74 out of 95 patients with DPLD, a diag-
osis was made with the use of large forceps, compared
o 62 out of 95 with the use of smaller forceps. How-
ver, there was one major limitation. In the 74 patients
n whom the large biopsy technique was considered to be
uccessful, the underlying diagnoses were forms of inﬂam-
atory DPLD. By contrast, in the 21 undiagnosed cases in
his series, the most frequent diagnosis at SLB was UIP/IPF,
ollowed by ﬁbrotic NSIP and chronic hypersensitivity pneu-
onitis. Thus, although undoubtedly promising, this method
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is yet to be validated in the diagnosis of IPF or the other
IIPs.
In the ﬁeld of DPLDs, the accurate identiﬁcation of IPF
remains the cardinal diagnostic challenge. In other disor-
ders, anti-inﬂammatory treatment is often successful. In IPF,
long-term stabilization of disease is not a realistic goal and
enrolment in trials of novel therapeutic agents is strongly
recommended in recent guideline statements. This crucial
treatment dichotomy should not be based on biopsy samples
which are small in size and must necessarily be associated
with major interobserver variation and sampling error. At
present, TBLB samples, although useful in other contexts,
are patently inadequate for this purpose.
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